"The U.S. Food and Drug Administration today notified Ranbaxy Laboratories, Ltd., that it is prohibited from manufacturing and distributing active pharmaceutical ingredients (APIs) from its facility in Toansa, India, for FDA-regulated drug product"...
Because of the anticoagulant effect of protamine sulfate (protamine (protamines) s) , overdosage of this drug may theoretically result in hemorrhage.However, in one study, overdosage of 600 to 800 mg of intravenous protamine sulfate (protamine (protamines) s) had only minimal, transient effects on blood coagulation tests.The patient should be followed with coagulation studies and treated symptomatically.
The LD50 of protamine sulfate (protamine (protamines) s) is 100 mg/kg in mice.
Protamine sulfate (protamine (protamines) s) is contraindicated in patients who have shown previous intolerance to the drug.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 11/21/2008
Additional Protamine Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.